Treatment-resistant schizophrenia: How far have we traveled?
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications resulting in incomplete functional and social recovery from the illness. Different definitions have been proposed for clinical practice and research work. Antipsychotics that are used in the management of s...
Main Authors: | Ambu Pandey, Kamal Narayan Kalita |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.994425/full |
Similar Items
-
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016-11-01) -
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
by: Frederick C. Nucifora, Jr., et al.
Published: (2019-11-01) -
Ethnopsychopharmacology: Clinical and scientific writing pearls
by: Jonathan G. Leung, PharmD, BCPS, BCPP
Published: (2023-12-01) -
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
by: Ming-Huan Zhu, et al.
Published: (2022-10-01) -
Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review
by: Jiangbo Ying, et al.
Published: (2023-03-01)